Trial of AD036 in Obstructive Sleep Apnea
Public ClinicalTrials.gov record NCT03845023. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double blind, placebo-controlled, repeat-dose, parallel arm, outpatient and inpatient phase 2 clinical study to examine the efficacy and safety of three dose levels of AD036 versus placebo in patients with obstructive sleep apnea.
Study identification
- NCT ID
- NCT03845023
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 25 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2019 (Actual)
- Primary completion
- Oct 23, 2019 (Actual)
- Completion
- Oct 23, 2019 (Actual)
- Last update posted
- Jan 17, 2023
2019
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pulmonary Associates | Glendale | Arizona | 85306 | — |
| Preferred Research Partners, Inc. | Little Rock | Arkansas | 72211 | — |
| Stanford Sleep Medicine | Redwood City | California | 94063 | — |
| SDS Clinical Trials, Inc. | Santa Ana | California | 92705 | — |
| Santa Monica Clinical Trials | Santa Monica | California | 90404 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Norton Clinical Research Group | Louisville | Kentucky | 40218 | — |
| The Center for Sleep and Wake Disorders | Chevy Chase | Maryland | 20815 | — |
| Sleep Medicine & Research Center, St. Luke's Hospital | Chesterfield | Missouri | 63017 | — |
| Clinilabs Drug Development Corporation | New York | New York | 10019 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| Sleep Therapy & Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03845023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03845023 live on ClinicalTrials.gov.